Related Experiment Video
Updated: May 30, 2026
09:47
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
From serendipity to mitochondria-targeted nanocarriers
1Midwestern University College of Pharmacy Glendale, Glendale, Arizona, USA. vweiss@midwestern.edu
Pharmaceutical Research
|August 12, 2011
Summary
A serendipitous lab discovery led to organelle-targeted pharmaceutical nanocarriers. These nanocarriers selectively deliver drugs and DNA to mitochondria in mammalian cells, advancing drug targeting technology.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Cell Biology
Background:
- Mitochondria play crucial roles in cellular functions and disease.
- Targeting mitochondria offers a promising strategy for novel therapeutics.
- Previous methods for organelle targeting were limited.
Purpose of the Study:
- To review the development of organelle-targeted pharmaceutical nanocarriers.
- To discuss applications in mitochondria-specific drug and DNA delivery.
- To explore the current state and future perspectives of mitochondrial drug targeting.
Main Methods:
- Review of literature on self-assembling molecules and nanocarrier development.
- Analysis of studies demonstrating subcellular delivery to mitochondria.
- Discussion of applications in drug and DNA delivery systems.
Main Results:
- A fortuitous discovery enabled the creation of nanocarriers for selective mitochondrial delivery.
- These nanocarriers facilitate the delivery of biologically active molecules to mitochondria.
- Established applications and potential for mitochondria-specific therapies.
Conclusions:
- Mitochondrial drug targeting technology has advanced significantly due to nanocarrier development.
- Organelle-targeted nanocarriers hold great promise for future therapeutic strategies.
- Further research into mitochondrial drug targeting is warranted.
More Related Videos
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
01:39Mitochondrial Protein Sorting
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death. Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
01:34Protein Transport into the Inner Mitochondrial Membrane
Nuclear encoded mitochondrial precursors are imported to the inner membrane in a multistep process involving two separate translocons, TIM22 and TIM23. TIM23 is a cation-selective pore that remains closed by the N terminal segment of the protein. Negative charges on the TIM23 act as a receptor for the incoming precursor, pulling the positively charged matrix-targeting sequence for peptide insertion and translocation.
Transport of mitochondrial precursors across the TIM23 channel is driven by...
Transport of mitochondrial precursors across the TIM23 channel is driven by...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:39Mitochondrial Precursor Proteins
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...
Most of the mitochondrial precursors...